Jump to Main Content
Enhancement of himastatin bioproduction via inactivation of atypical repressors in Streptomyces hygroscopicus
- Xie, Yunchang, Li, Qinglian, Qin, Xiangjing, Ju, Jianhua, Ma, Junying
- Metabolic Engineering Communications 2019 v.8 pp. e00084
- Streptomyces hygroscopicus, biosynthesis, enzymes, gene activation, high performance liquid chromatography, multigene family, mutants, quantitative polymerase chain reaction, regulator genes, reverse transcriptase polymerase chain reaction
- Three atypical regulatory genes, hmtABD have been discovered within the himastatin biosynthetic gene cluster (BGC) in Streptomyces hygroscopicus ATCC 53653 and the roles of their products have been identified. HmtA and HmtD do not show any structurally distinct features characteristic of regulatory function yet were shown to play important repressive and stimulatory roles, respectively, related to himastatin biosynthesis. HmtB encodes a conserved acetylglutamate kinase; new member of this family serves as repressor of secondary metabolism. Through repressive networks engineering, the limiting functions of HmtA and HmtB along with the activating functions of HmtD in the himastatin BGC have been identified for the first time by gene activation, qPCR, RT-PCR and HPLC studies of selected mutant strains; two of these mutant strains (ΔhmtA and ΔhmtB) produced himastatin in titers (19.02 ± 1.2 μg/mL, 9.9 folds and 30.40 ± 0.83 μg/mL, 15.8 folds) far exceeding those of the wild-type (WT) producer. Overall, this work provides significant insight into secondary metabolic regulatory mechanisms in Streptomyces. These efforts also highlight and validate a new strategy enabling expanded exploitation of cyclopeptidic natural products such as himastatin that demonstrate exciting antimicrobial and antitumor potentials.